Inhibition of Melanization in Human Melanoma Cells by a Serotonin Uptake Inhibitor  by McEwan, Max & Parsons, Peter G.
Inhibition of Melanization in Hutnan Melanotna 
Cells by a Serotonin Uptake Inhibitor 
Max M cEwan, B.Sc. and Peter G. Parsons, Ph.D . 
Qu ecnsland Instiw te of Med ica l Resea rch, Herston, Q ueensland, Austra li a 
Significant levels of intracellular ca techolamines were fo und 
in a human melanoma cell lin e and were enhan ced by in-
creasing the extracellular tyrosine concentration. Intracel-
lular dopa, 5-cysteinyldo pa, ty rosin ase, and melanin also 
rose under these conditions. 5-HT (se rotonin) was syn-
thesized by the melano m a cell s but further stud y was hind-
ered by the hi gh level of5-HT in feta l ca lf se rum . A 5-HT 
uptake antagonist, DU 24565 (6-nitroguipazine), was em-
ployed as an altern ative method for studyin g 5-HT action. 
T his compound , w hich in contras t to tunica m ycin had no 
M elanin biosy nthesis has been the m ost intensively stu died aspect of differentiation in melanoma, . yet few m eta stases in hum ans and few hum an melanom a cell lines show signifi ca nt activity in this pathway . It is possible that other phenomena 
related to the neural cres t o rig in of melanom a may be exp ressed 
and have fun ctio nal relevan cc in a hi gh proportio n of these tu-
mo rs . Many melanomas, for exam ple, exp ress the S-100 protcin 
[11 and neu rone-speci fi c eno lase [2]. In addi ti on, several studies 
suggest that melanoma cells are ca pab le of synth es izin g ca te-
cho lamines . E levated dopam ine [31 and 5-hydroxytryptamin e 
(serotonin) (5-HT) [41 were repo rted in patients with melano ma , 
ca techo lamin es were detected in the culture m ed ium of melano m a 
cell lines [5], do pamin e antagoni sts have been used to m od ul ate 
the gro wth of m elanoma [6,7], and it is possib lc that the form-
aldehyde- induced flu orescence ill m elanotic and 3melanotic cell s 
[8 ,9 \ ar ises from a reactio n w ith catecho lam ines as wcll as w ith 
dopa and 5-cysteinyldopa. 
As pa rt of a stud y of th e express io n of neura l crest properties 
in hum an melanoma, we have found that a m elano m a ce ll line 
synthesizes 5-H T and a var iety of ca techolamines , and that a 5-
HT antago nist inhibits m elani za tion w itho ut affectin g tyrosinase 
ac ti vity. 
MATER IALS AND M ETHODS 
The MM 96E hum an melano m a cell line is a slightl y pigmented , 
ncar-diploid subline of MM96, deri ved fro m a melanoma me-
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Abbreviations: 
DFM O: cr-diAuoro meth ylo rnithine 
DOPAC: 3,4-dih yd roxyphen ylacetic acid 
DU 24565: 6-nitroquipazinc 
HPLC: high-performance liqu id chromatog raph y 
5-HT: 5-hyd rox ytryp talllinc (se roton in) 
PB S: phosphate-buffered sa line, pH 7.2 
inhi bito ry effects on cell proliferati on o r ty rosinase acti vity, 
strongly inhibited m elaniza tion and decreased the levels of 
dopa, 5- cys tein yldopa, dopa mine, noradrenaline, adrena-
line, and 3,4-dih ydroxyph enylace ti c acid. DU 24565 had 
little effec t on 5-HT or tyrosine accu mulation in these cells 
but suppressed the uptake of ex tracellular do pa. T he results 
show that hum an melano m a cel ls synthesize a w ide range 
of biogenic amines in culture and sugges t a new approach 
to regul ating intracellular levels of dopa and of a variety 
of dopa produ cts. J JlI lles t Dermato! 89:82-86, 1987 
tas tasis [1 0]. Routin e assays fo r Mycop lasl/"/lI usin g aga r culture 
were nega tive. Cells were cultured as ll1 ono layers in 15 cm pl ates 
usin g Hoswell Park M em orial In stitute m ed ium 1640 supple-
mented wi th 10% (v/v) fetal ca lf serum, 100 unitslIul penicillin , 
l OO JLg/ ml streptomycin and 3 mM 4- (2-hyd roxyeth yl)-1-piper-
azine-eth anes ulfonic acid. 5-Cys tein yldo pa was prepared and pu-
rifi ed as desc ribed prev io usly 1.11] . DU 24565 (6-nitroquipazine) 
was donated b y Duphar Labo ratories, Southampton, U .K . Un-
less otherw ise sta ted , 0.56 m M tyrosine in culture m edium was 
used to stimulate m elani za ti on . For so m e experim ents, th e serum 
was dia lyzed at 2°C fo r 24 h against 2 changes of m edium 1640. 
For determinatio n of intracellular constituen ts, cellmo nolayers 
were washed twice w ith phos phate-bu ffe red sa line (PBS, pH 7.2) , 
harves ted with a pl astic scraper, and taken up in 1 ml PBS con-
tainin g antiox ida nt fo r ex tract ion w ith a boron ate sys tem as pre- ' 
viously described [1 21. 3,4-Dih ydro xy benzylamine added befo re 
ex traction served as an intcrn al standard to adjust fo r differences 
in recovery. Catecho lamines in th e extra ct were separated by 
hi gh-perform ance liquid chro m atograph y (HPLC) with an SSI 
Sys tem s 3 pump (Sta te College, Penn sylvania) and a Rainin C -
18 reverse phase 3 JL si lica 10 cm co lu mn (Woodburn , M assa-
chuset ts) at 0.9 ml / min . The m o bile phase was 0 .15 M chl oroacetic 
acid , 0.67 m M EDTA and 0.85 m M sod ium octany l sulfonate 
(depcndin g on co lumn age), pH 3, and was recycled under helium 
(Ultrapure, Commo nwealth Industri al Gases, Brisbane, Aus-
tralia). Compound s were detected and quantitated by a Yanaco 
dual channel electrochemi cal detector VMD-501 (Y anagimo to 
M anu f. Co., K yoto , Japan) o perating at 0.6 volts (Agi AgCI ref-
erence) and 1 nA fu ll scale sensitivity. Identity of pea ks was es-
tablished by spiking the sa mple with kn own standards. Extra-
cellular ca techo lamin es were assayed by extracting 2 ml of culture 
fluid and anal ys in g as described above. 
For extraction of 5-HT from cells, the pellet was sonicated in 
1 ml of 0.2 N pcrch lo ri c acid at O°C for 1 min , centrifu ged, and 
the supernatant filtered through a 0.2 JL Rainin microfi lter. Anal-
ys is by HPLC and electrochemi ca l detectio n was ca rried o ut as 
above, except that the m obil e phase had 5% m ethano l added. 
C ulture medium was acidified with perchloric acid to a fin al 
concen tration of 0.2 N and anal ysed for 5-HT as described above. 
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Table I. Stimu lati on of th c Ca tccholaminc and M elanization 
Path ways in Hum an M clano ma Cell s 24 Hours After 
Supplemcntati on of Ex tracellul ar T yrosinc 
Cell Constituent 
(ng/3 x 10') cel ls)" 
T yros ine in C ulture M ed ium 







T yrosin ase' 
Melanin 
15 ± 1 
7.3 ± 0.2 
16 ± 2 
2.8 
"Packed cell vo lum e = I ml. 
''Normal le vel in 1640 med ium . 
'J.L mole dopa / minIlO" cell s. 
' Mea n and SO o f tr iplica tes. 
'NT. not tested. 
0.28 mM 
2. 1 ± 0.3" 
2.8 ± 0.3 
39 ± 2 
34 ± 4 
24 ± 2 
NT' 
0.56 mM 
3.5 ± 0.2 
7.4 ± 0.8 
72 ± 8 
65 ± 2 
33 ± 4 
14 
T yrosinase (do pa oxidase) acti vities were dctermined by son-
ication of cells in PBS containin g 0. 1 % Brij 35, centrifuga tion at 
100,000 g for 30 min and add ition of a 10 p,1 aliquot of th e su-
pernatant to 100 p,1 of a mi xturc of 7.6 111M dopa and 50 111M 
phosphate buffer (p H 6.8) in the well o f a mi crotitre plate. The 
increase in absorbance at 485 nm w as read at 5 min interva ls in 
an enzy m e-li nked immunosorbcllt assay rcader (Model EL310, 
Bio-Tek Instruments, Burlington, Virginia). Melanin content was 
assayed by addin g 0.5 ml Solucne 350 (Packard Instruments, Z u-
ri ch, Switzerland) to the dark pellet in th e aq ucous layer from 
the first ca techo lamin c cxtrac ti on step . After 30 min at 56°C, th e 
solution w as diluted with 1 ml to luene and th e absorbance read 
at 405 nm. Dopa-melanin (Sigma, St. Louis, Misso uri) was used 
as a standard. The procedure was also ca rried out with non mel-
anized cells (H eLa) to show th at abso rbance at thi s wavclength 
was negligible. 
Tyrosine uptake was determined by trcating ccll m ono layers 
w ith [U-' 4C] tyrosinc (0.5 p,C i/ ml , 0.56 mM) in mcd ium for 24 
h, harvcstin g as described above and liquid scintill ati on co unting 
of celJs in Instagel (Packa rd Instrum ents) aftcr lys is in 1 ml of 
0.2% sodium dodccyl sul fatc. 
RESULTS 
Catecholamine and 5-HT Synthesis by Human Melanoma 
Cells, and Stimulation by Extracellular Tyrosine Ana lyzed 
by HPLC w ith e1cctrochcl11i cal detection , the MM96E cell line 
was found to contain signjfi ca nt levels of ad renaline and dopamine 
as well as th e m elanin precurso rs dopa and 5-cys teiny ldopa (Table 
I). In subsequ ent experiments the HPLC param eters were set to 
accuratel y detcct th e hi gh levels induccd by tyros ine; on ly the 
Table II. Inhi bition of Dopa Uptake and Ca tccholamine 







N o radrenaline 
5-Cystein yldo pa 
Intracel lular Catechol Levels 24 h After Various 
Additi ons to the C ulture M edium 
Contro l 
Medium 






Med ium Pl us Dopa 
(0.5 JLg/ ml) 
100 ± 0.7 
16.9 ± 1. 4 
36.7 ± 0.4 
6.4 ± 0.1 
16.5 ± 1.3 
9.3 ± 0.8 
Medium Plus Dopa 
(0.5 JLg/ ml) and 
DU 24565 
(10 JLg/ ml) 






"Mean and SO for triplica tes. 
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Table III. 5-HT in MM 96E Cell s and C ulturc Med ium 
5-HT (ng / ml) 
In medium 
Medium Used fo r 
C ulturing Cell s Before C ulture 
After C ulture 
fo r 7 Days In cell s" 
Serum not dialyzed 
Dia lyzed serum 
14.5 /0 
< 0.3 
"Packed cell vo lume (3 X la" ce lls/ ml). 





uppcr limits (set by the H PLC conditions) are indicated for un-
stimu latcd cells in T able II. 3,4-Dih ydroxyphenylacetic acid 
(DOPA C) was also present whereas noradrcnaline could not usu-
all y be dctccted unless the cclls we re stimulated by tyrosinc (sce 
below). T hcse prod ucts were also fo un d in MM96E culture mc-
dium , but no t in H eLa cell s or in medium from HcLa, a non-
mclano ma linc (res ults not shown). 
Whcn a confluent monolaye r of MM96E cel ls was incubated 
for 24- 48 h w ith culturc mcdium co ntaining a 2- fo ld o r 4-fold 
Icvcl of ty ros inc, p rolifera tion ccased .and th e cclls beca m c den-
dritic and hcavil y melanized . A sim ilar effcct has been reportcd 
in murine melanoma ccJJ s [1 3J. T he levels ofty ros inasc and catc-
cho lamines also increascd up to 9- fold (Ta ble I). T his phenom-
cnon was subscqucntl y cmpl oyed to determinc th c effccts of in-
hibi tors on melanization . 
T hc abovc findi ngs raised thc ques ti on of w hether 5-HT, an-
o ther ncural crcst amin c, was prod uccd by melanoma ccll s. Al-
though elevatcd in melanoma paticnts [41, 5-HT co ul d no t prc-
viously be detected in the culture med ium from melano ma ceJJ 
lines (5). Preliminary ex perim ents showcd that 5-HT was already 
ab undan t, although ' in va ri able amounts, in feta l ca lf scrum and 
could bc rem ovcd by dialysis (Ta ble III ). T he poor growth of 
ccJJs in dia lyzed scrum limited the range of expcriments possibl e 
and led to use of thc an ti scrotoninergic agent DU 24565 as an 
altern ati vc approach to stud ying th e effect of5-HT on thc mclanin 
path way (see below). However, by growing MM96E cclls in 
sevc ral changes o f di alyzed med ium for 2 wccks it was possible 
to demonstratc 5- HT synth esis bccause th e intracellul ar 5-H T 
Icvel was maintained des pitc cell division, and 5-HT was excrctcd 
in to thc culture medium (T able lll ). 
Effect of Inhibitors on Melanization Conflucnt monolayers 
of tyros ine-stimu lated MM96E cell s we re used to compare thc 
cffects of th e 5-HT uptake antagoni st DU 24565 [1 4] with those 
of o th er inhi bitors (Table IV ). DU 24565 inhibi ted dopa and 
melan in synthes is without affecting tyros inase acti vi ty; and, thc 
lattcr was no t inhibited by DU 24565 added directl y to celllysa tcs 
(rcsults not shown). The glycosylation inhibitor tunica m ycin (15) , 
howcver, deprcsscd dopa , melanin , and tyrosinase. DFMO (a-
Table IV. Effect o f 36-Hour Treatment With DU 24565, 
DFMO , o r T uni ca mycin on the Melanin Path way in MM96E 
Cclls Stimulatcd With 0 .56 mM Tyrosine 
Cel l CO lllpo nent 
Dopa Melani n Tyrosinase 
(ng/3 X 10" (ng/3 X 10') (JLlll ol dopa / 
Inhibi tor cel ls) cells) min i I 0" cel ls) 
Control 31 ± 21  2.8 20 ± 0.2 
DU 24565 (10 JLg/ ml) 17 ± I 2.0 ± 0. 1 20 ± 0.1 
Tunicamycin (.I JLg/ ml) 19.3 ± I 1.7 ± 0.4 11 ± 1. 5 
DFMO (400 JLg/ ml) 77 ± 8 5.7 ± 0.4 38 ± 0 
"Mean and SO fo r tri pli cates. 
Key: OFMO = a -diRuo ro lll cth ylo rnithine. 
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difluoromethylornithine), which induces melanization indirectly 
through differentiation [16], enhanced melanization in the MM96E 
linc with concomitant increases in dopa and tyrosinase levels. 
Tyrosine-stimulated melanization and its inhibition by DU 24565 
and tunicamycin were time dependcnt. The level of the melanin 
precursors 5-cysteinyldopa and dopa (Fig 1A,C) increased 48-72 
h after stimulation whereas melanin was elevated after 24 h (Fig 
1 B) . Inhibition of melanization by DU 24565 was maximal 24-48 
h after stimulation . The increase in adrenaline observed 72 h after 
add ition of tyrosinc w as inhibited by DU 24565 (Fig 1P) . The 
experiment was not continued beyond 72 h because although 
melanization increased still further the cells became rounded, de-
tached from the plate, and lost viability. The levels of noradren-
aline and dopamine were influenced in a similar manner to ad-
renaline (Fig 2A,B) . Production of DOPAC, like dopa, was 
stimulated at an earlicr stage (Fig 2C). Tunicamycin was less 
inhibitory than DU 24565 for melanin and DOPAC synthesis; 
the levels of the other 5 catechols were decreased by similar amounts. 
Q ualitatively similar results were obtained in repeated experi-
ments; however, some variation in thc absolute levels of inhibition 
were found ~ presumably due to variation in cell density at the 
time of tyrosine stimulation . 
It was possible that DU 24565 on ly affected melanization when 
the latter was stimulated by high levels of tyros ine. Using normal 
medium however, melanization could be induced in confluent 
cells when not fed with frcsh medium for 4 days. Under thcsc 
















24 48 72 
Treatment Time (hr) 
Figure 1. Inhibition by DU 24565 of melanin and catechol levels induced 
in MM96E cells by 0.56 mM tyrosine. Intracellular levels are expressed 
as a percentage of thc 72-h control. A, 5 Cystcinyldbpa; B, melanin; C, 
dopa ; and D, adrenaline. Opell circles, control; closed circles, 10 p.g/ml DU 
24565; closed squares, 1 p.g/ml tunicamycin. Poillts are means and SD of 
triplicatcs . 
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Figure 2. Inhibition by DU 245650[0.56 mM tyrosine-stimulated cate-
cholamine levels. Intracellular levels are expressed as a percentage of the 
72-h control. A, Noradrenaline; B, DO PAC; and C, dopamine. Opell 
circles, control; closed circles, 10 p.g/ ml DU 24565; clos~d sqllares, 1 p.g/ ml 
tunicamycin . Poillts are means and SD of triplicates. 
catecholamines (Table V). DU 24565 did not inhibit cell prolif-
eration at the levels uscd in thc abovc experimcnts. Ano thcr hu-
man melanoma cclllinc with a high constituti ve level of melanin 
bccame less pigmented whcn cultured in normal mcdium ill the 
prcsence of DU 24565 for several weeks (results not shown). 
Effect of DU 24565 on the Uptake of 5-HT, Tyrosine, and 
Dopa Unlike other substituted piperazines, which rclease 5-HT 
[17], DU-24565 was reportcd to specificall y inhibit 5-HT uptake 
[14]. To determine w hethcr DU 24565 was antiscrotonincrg ic in 
MM96E, the cells were cultured for sevcn days in m edium con-
taining dialyzed serum and then treated with 5-HT. Thc dose 
response for 5-HT uptake stud ied after 24 hours (Fig 3) showed 
inhibition by DU 24565 onl y at thc lowest levels used (2-5 ng/ ml 
5-HT). Uptake of tyrosine in tyrosine-supplemented mcdium 
(0.56 mM) was 0.008 pmol/cell in 30 min (0.023 pmol/cell ovcr 
24 h), and was not affected by DU 24565 (resu lts not shown). 
Depression by DU 24565 of melanization and intracellul ar dopa, 
without inhibiting tyrosinase, cou ld have been due to inhibitcd 
uptake of dopa recycled from the extracellular pool. The time 
period avai lable for studying such cffects was limited by the fact 
that dopa added to cu lture medium undergoes auto-oxidation 
with a half-life of approximately 5 h , with gradual formation of 
melanin in the medium and cells. Twenty-four hours aftcr adding a 
low level of dopa to the culture medium , significant increases in 
intraccllular dopa and catecholamines were obscrved in MM96E; 
this response was completely inhibited by DU 24565 (Table II ). 
Table V. Inhibition of Catecho lamine Levels and 
Melanization by DU 24565 in the Absence of 
Tyrosine Stimulation 
Cell Component Control 
(ng/3 X 10') cells) Cclls PIllS DU 24565" 
Adrenalinc 3.3 :±: 1.0" 1.2 :±: 0.3 
Dopamine 1.2 :±: 0.2 < 0.1 
Dopa 35 :±: 2 11 :±: 2 
5-Cystciny ldopa 1. 9 :±: 0.2 0.4 
Mclanin 4.4 :±: 0.4 1. 8 :±: 0.3 
"4-day treatm ent w ith 10 /Lg/ ml DU 24565 in medium containing the normal 
level of tyrosine (0.1 4 mM) 
"Mean and SD for triplicates. 
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Extracellular 5-HT (ng / ml) 
Figure 3. Effect of DU 24565 o n 24-h uptake of exogenous 5-HT by 
MM96E ce ll s precultllred in dia lyzed serum. OpCII circles, control ; closed 
circles, 10 I-tg / ml DU 24565. The intrace llular level is based o n the packed 
cell vo lume (3 x 10') cells/ ml). Poi/lis arc mcans and SD of triplicates. 
D ISCUSS ION 
These findin gs describe several properties of melano ma cells re-
lated to the neura l crest and suggest a new approach to modu lating 
melanogenesis in vitro and poss ib ly in vivo. Production by mel-
anoma cells of 4 ca techo lamines was documented in one cell line 
and has been found in all other melanom a lines so far tes ted , 
whether melanotic or no t (unpublished results). Catecho lamine 
synthesis m ay th erefore be a more general pathwa y of tyrosine 
metabolism in melano ma than melani zation, and m ay be the site 
of action for a-recepto r anta goni sts such as papaverine, a com-
pound previously repo rted to inhibit pro liferation and melani-
zation in melanoma [1 8]. The presence of ca techolamines ma y 
also acco unt for the form aldeh yde-indu ced flu o rescence found in 
amelanotic melanoma [8,91 where the levels of dopa and 5-cys-
tein yldopa are very low (unpublished results) . 
5-HT synthesis was signifi cant in that the extracell ular level 
approached the no rma l ran ge of12-45 ng/ ml for plasma [1 9] and 
that culture medium m ay contain high levels of 5-HT. It may be 
diffi cult to directl y tes t the effect of ph ysiologic levels of 5-HT 
on cell g rowth and melaniza tion under conditions of max imum 
cell via bility. It will be ofintcrest, however, to dcterminc whethcr 
ca techol amines and 5-HT arc synthcsized by normal and prcneo-
plasti c m elanocytcs, and whether cnvironmcnta l agcnts sllch as 
solar radiation have loca l o r systemic cffects on these systems. 
The fact that DU 24565 blocked melaniza tion without inhib-
iting tyrosinase o r cell viability points to an action diffcrcnt fro m 
th at o f reportcd mclanization inhibitors such as hydroquinone 
[20] and tunicam ycin [15]. Further study of this mechanism , af-
fecting perhaps thc synthesis, deg radation , or cfflux of catcchols, 
may reveal other ways of modifying the behavior of melanogcnic 
cells. The simi lar cffects of tunicamycin and DU 24565 on ca-
techols suggest only that the lcvel of thc prccursor dopa is affected 
by bo th dru gs; the fact that tuni cam ycin was less cffectivc in 
inhibiting melanin and DOPAC synthesis may bc duc to an ad-
ditional effect of D U 24565 on late stages in both pathwa ys. The 
present evidence does no t support an antiserotoninergic action 
for DU 24565 [14J in the MM96E line, but instead showed a very 
strong inhibitory effect on the uptake of dopa. Dopa is a key 
intermediate in melanogenes is and catecho lamine synthesis, and 
is a cofactor for tyrosinase [21 J. DU 24565 m ay therefore act by 
depressing the intracellular dopa levcl, either through faci litatin g 
efflu x from th e cel l or throu gh some other effect on dopa transport 
or metabolism. 
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Dopa uptake invo lves sa turable, ca rrier-medi ated transpo rt in 
compctition with othcr aromati c amino acids 122J. The fact that 
dopa but not tyrosinc was depl etcd suggcsts that DU 24565 has 
a vcry specifi c effect on this sys tcm. Murine m elano ma m odels 
havc intrinsic [23] or inducible [24J ability to selectively accu-
mulate dopa in vivo , but MM96 cells do not sho w prefcrcntial 
uptake of dopa in cu lturc compared with HcLa [251 . Thc DU 
24565-sensitive dopa transport phenomeno m may th ercfo re bc 
prcsent in nonmelanocy tic cclls, and m ay provide a control point 
for overcoming the problems [26] of maintaining a stab le ther-
apeutic cffect of dopa in vivo. 
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